Caption Management’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
RCM
ACA
Caption Management's ASND Position: Q3 2025 in Review
Caption Management sold out of Ascendis Pharma A/S (ASND) in Q3 2025, closing a stake of 6,499 shares — an estimated $1.21M sold.
Caption Management first reported a position in ASND in Q3 2019 and held it in 10 quarters. The position peaked at $6.25M in Q4 2024. 279 funds tracked by Wall St. Rank hold ASND as of Q3 2025.
- Caption Management reported no remaining Ascendis Pharma A/S position as of Q3 2025 after selling out during the quarter.
- Caption Management sold 6,499 Ascendis Pharma A/S shares in Q3 2025, an estimated $1.21M.
- Caption Management first reported a position in Ascendis Pharma A/S in Q3 2019 and held it in 10 quarters.
- Caption Management's Ascendis Pharma A/S position peaked at $6.25M in Q4 2024.
- 279 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2025.
Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.